Highbridge Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-100,000
| Closed | -$2.24M | – | 1018 |
|
|
2018
Q1 | $2.24M | Hold |
100,000
| – | – | 0.04% | 340 |
|
|
2017
Q4 | $2.5M | Buy |
100,000
+49,177
| +97% | +$1.23M | 0.04% | 296 |
|
|
2017
Q3 | $1.23M | Buy |
50,823
+40,823
| +408% | +$987K | 0.02% | 389 |
|
|
2017
Q2 | $202K | Sell |
10,000
-18,345
| -65% | -$371K | ﹤0.01% | 744 |
|
|
2017
Q1 | $763K | Sell |
28,345
-10,651
| -27% | -$287K | 0.01% | 596 |
|
|
2016
Q4 | $741K | Sell |
38,996
-40,227
| -51% | -$764K | 0.01% | 541 |
|
|
2016
Q3 | $1.55M | Buy |
79,223
+43,646
| +123% | +$853K | 0.02% | 428 |
|
|
2016
Q2 | $533K | Sell |
35,577
-28,968
| -45% | -$434K | 0.01% | 658 |
|
|
2016
Q1 | $594K | Buy |
+64,545
| New | +$594K | 0.01% | 511 |
|